Wanzun Lin

1.1k total citations
42 papers, 804 citations indexed

About

Wanzun Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wanzun Lin has authored 42 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Wanzun Lin's work include Ferroptosis and cancer prognosis (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer-related molecular mechanisms research (6 papers). Wanzun Lin is often cited by papers focused on Ferroptosis and cancer prognosis (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Cancer-related molecular mechanisms research (6 papers). Wanzun Lin collaborates with scholars based in China, United States and France. Wanzun Lin's co-authors include Xianxin Qiu, Sufang Qiu, Long Chen, Youliang Weng, Yuling Ye, Jiade J. Lu, Qingting Huang, Shihong Wu, Xianhe Xie and Yuhui Pan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Wanzun Lin

41 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanzun Lin China 15 383 239 238 238 155 42 804
Arjan Kol Netherlands 12 269 0.7× 89 0.4× 228 1.0× 409 1.7× 251 1.6× 15 817
Xu Shi China 15 263 0.7× 125 0.5× 156 0.7× 72 0.3× 135 0.9× 32 677
Zhixin Qiu China 20 333 0.9× 133 0.6× 199 0.8× 216 0.9× 147 0.9× 49 790
Yating Zhang China 11 166 0.4× 106 0.4× 146 0.6× 163 0.7× 88 0.6× 30 569
Jilin Li China 17 453 1.2× 241 1.0× 120 0.5× 234 1.0× 131 0.8× 51 840
Alesia Ivashkevich Australia 10 405 1.1× 194 0.8× 224 0.9× 219 0.9× 42 0.3× 15 758
Ilenia Aversa Italy 15 591 1.5× 483 2.0× 436 1.8× 160 0.7× 92 0.6× 21 1.0k
Tianyun Qiao China 10 543 1.4× 416 1.7× 132 0.6× 261 1.1× 148 1.0× 17 938
Chitra Joseph United Kingdom 19 390 1.0× 262 1.1× 227 1.0× 354 1.5× 159 1.0× 36 923

Countries citing papers authored by Wanzun Lin

Since Specialization
Citations

This map shows the geographic impact of Wanzun Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanzun Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanzun Lin more than expected).

Fields of papers citing papers by Wanzun Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanzun Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanzun Lin. The network helps show where Wanzun Lin may publish in the future.

Co-authorship network of co-authors of Wanzun Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Wanzun Lin. A scholar is included among the top collaborators of Wanzun Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanzun Lin. Wanzun Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Li, Wanzun Lin, Shikai Geng, et al.. (2024). TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis. Cell Death and Disease. 15(3). 178–178. 25 indexed citations
2.
Geng, Shikai, Li Chen, Wanzun Lin, et al.. (2024). Exploring the Therapeutic Potential of Triptonide in Salivary Adenoid Cystic Carcinoma: A Comprehensive Approach Involving Network Pharmacology and Experimental Validation. Current Pharmaceutical Design. 30(29). 2276–2289. 1 indexed citations
3.
Huang, Zongwei, Ying Li, Xiaochuan Chen, et al.. (2024). SPP1-mediated M2 macrophage polarization shapes the tumor microenvironment and enhances prognosis and immunotherapy guidance in nasopharyngeal carcinoma. International Immunopharmacology. 147. 113944–113944. 9 indexed citations
4.
Huang, Qingting, Jiyi Hu, Li Chen, et al.. (2023). Carbon ion radiotherapy combined with immunotherapy: synergistic anti-tumor efficacy and preliminary investigation of ferroptosis. Cancer Immunology Immunotherapy. 72(12). 4077–4088. 7 indexed citations
6.
Lin, Wanzun, Christian P. Bromley, Gustav Jonsson, et al.. (2023). NKG2D Fine-Tunes the Local Inflammatory Response in Colorectal Cancer. Cancers. 15(6). 1792–1792. 6 indexed citations
7.
Lin, Wanzun, Li Chen, Xianxin Qiu, et al.. (2022). Identification of molecular subtypes based on inflammatory response in lower-grade glioma. Inflammation and Regeneration. 42(1). 29–29. 11 indexed citations
8.
Lin, Wanzun, Yanyan Xu, Jing Gao, et al.. (2021). Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology. 12. 757047–757047. 12 indexed citations
9.
Chen, Xiaochuan, Chao Li, Ying Li, et al.. (2021). Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma. Frontiers in Molecular Biosciences. 8. 727481–727481. 11 indexed citations
10.
Lin, Wanzun, Xianxin Qiu, Yuling Ye, et al.. (2021). Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma. Molecular Therapy — Oncolytics. 21. 288–302. 28 indexed citations
11.
Wang, Xinwen, Liangming Wang, Weifeng Xu, et al.. (2021). Classification of Osteosarcoma Based on Immunogenomic Profiling. Frontiers in Cell and Developmental Biology. 9. 696878–696878. 14 indexed citations
12.
Lin, Wanzun, Xiaochuan Chen, Ting Chen, et al.. (2020). C1QTNF6 as a Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma. DNA and Cell Biology. 39(6). 1000–1011. 15 indexed citations
13.
Lin, Wanzun, Shihong Wu, Xiaochuan Chen, et al.. (2020). Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups. Frontiers in Oncology. 10. 796–796. 127 indexed citations
14.
Sun, Yanan, Xianrong Lai, Yu Yan, et al.. (2019). Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Liu, Jun, Weifeng Tang, Wanzun Lin, et al.. (2019). Lack of Association Between CTLA-4 Genetic Polymorphisms and Noncardiac Gastric Cancer in a Chinese Population. DNA and Cell Biology. 38(5). 443–448. 11 indexed citations
16.
Liu, Jun, Miao Liu, Jiling Wang, et al.. (2019). Comparison of Three Different Assays for the Detection of Tumor Antigen-Induced Lymphocyte Transformation In Vitro. DNA and Cell Biology. 38(11). 1402–1410. 1 indexed citations
17.
Lin, Wanzun, Jun Liu, Juhui Chen, et al.. (2019). Peptides of tetraspanin oncoprotein CD151 trigger active immunity against primary tumour and experimental lung metastasis. EBioMedicine. 49. 133–144. 14 indexed citations
18.
19.
Xie, Xianhe, Yanfen Hu, Chao Jing, et al.. (2017). A Comprehensive Model for Predicting Recurrence and Survival in Cases of Chinese Postoperative Invasive Breast Cancer. Europe PMC (PubMed Central). 18(3). 727–733. 1 indexed citations
20.
Li, Lina, Heng Lin, Haitao Yang, et al.. (2017). Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer. Journal of Thoracic Disease. 9(8). 2510–2520. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026